DFX Intelligence
Borrowers
286 borrower groups currently held, grade A and BWhat a borrower group isA borrower group is every spelling of one credit agreement's borrower across the BDCs that hold it (Icefall Parent, Icefall Topco and Icefall Bidco are one). Grade A and B groups are listed; a short one-word stem (grade C) is kept apart and never merged across filers. Principal is the sum of BDC pieces and is a lower bound.Principal and marks are the filers' figures at each BDC's latest quarter end, summed. Maturity is the filer's tagged date or the date written into the identifier; a BDC that tags neither leaves it unstated.
Industry as filed contains “Healthcare” (remove)
Start from
286 borrower groups
| Borrower | Sponsor | BDCs | Principal held | On cost | Spread | Next maturity | First seen |
|---|---|---|---|---|---|---|---|
| RedMed Operations Life sciences | unattributed | 2 | at least $7.5M | 101c | n/a | Feb 28, 2031 | Mar 31, 2025 |
| Beacon Behavioral Support Service, LLC Education | unattributed | 2 | at least $7.2M | 110c | n/a | Jun 21, 2027 | Jun 30, 2024 |
| Athletico Holdings, LLC Healthcare services | unattributed | 6 | at least $7.0M | 46c | n/a | Feb 2, 2029 | Sep 30, 2022 |
| H••••••••• T••••••••• I•• Healthcare services | unattributed | 1 | at least $6.7M | 98c | n/a | Sep 30, 2026 | Dec 31, 2022 |
| E••••••• P••••••• Life sciences | Sponsor not establishedpossible: M••••••• C•••••• L•• (a company of this name is on the sponsor's portfolio page) | 2 | at least $6.6M | 101c | n/a | Oct 5, 2029 | Dec 31, 2023 |
| A••••••••• Life sciences | unattributed | 4 | at least $6.4M | 94c | n/a | Jun 20, 2028 | Dec 31, 2021 |
| I•••••••• H••••• P••••••••• L•• Healthcare services | unattributed | 2 | at least $6.0M | 101c | n/a | Feb 2, 2032 | Mar 31, 2026 |
| E••• S••••••• G•••• Life sciences | unattributed | 3 | at least $5.8M | 98c | n/a | Jun 28, 2029 | Dec 31, 2022 |
| A•••••• H•••••• G••• Life sciences | unattributed | 2 | at least $5.8M | 99c | n/a | Nov 29, 2032 | Dec 31, 2025 |
| S••••••••• D••• B••••• B••••••••• H•••••••• L•• Healthcare services | unattributed | 1 | at least $5.6M | 101c | n/a | Jun 21, 2030 | Sep 30, 2024 |
| J••• H•••••• I•• Healthcare services | unattributed | 1 | at least $5.5M | 101c | n/a | Aug 16, 2029 | Sep 30, 2024 |
| D••••• I•• Life sciences | unattributed | 3 | at least $5.5M | 100c | n/a | May 9, 2031 | Jun 30, 2024 |
| R••••••••• Life sciences | unattributed | 5 | at least $5.5M | 102c | n/a | Dec 19, 2030 | Dec 31, 2022 |
| E••• H••• H••••• S•••••••• I••••••••• L•• Education | unattributed | 3 | at least $5.4M | 94c | n/a | May 10, 2030 | Jun 30, 2024 |
| S••••• B••••••••• H••••••••• L•• Life sciences | unattributed | 6 | at least $5.0M | 74c | n/a | Dec 31, 2029 | Sep 30, 2021 |
| G••••• A•• Life sciences | unattributed | 3 | at least $5.0M | 100c | 0 pts | Dec 13, 2032 | Dec 31, 2025 |
| V•••• B••••• I•• Life sciences | unattributed | 2 | at least $4.9M | 100c | n/a | Dec 15, 2031 | Dec 31, 2024 |
| M••••• 5••• G••• Life sciences | unattributed | 2 | at least $4.6M | 101c | n/a | May 28, 2028 | Dec 31, 2021 |
| P••••• D••••••••• L•• Healthcare services | unattributed | 7 | at least $4.6M | 100c | n/a | Oct 20, 2029 | Dec 31, 2021 |
| R•••••••• Life sciences | Sponsor not establishedpossible: W••••••• H••••• I••••••••• L•• (a company of this name is on the sponsor's portfolio page) | 1 | at least $4.5M | 74c | n/a | Jul 21, 2028 | Dec 31, 2022 |
| Q••••••••• C••••••••• Life sciences | unattributed | 5 | at least $4.0M | 99c | n/a | Aug 20, 2032 | Sep 30, 2025 |
| M•••• • A••••••• Life sciences | unattributed | 1 | at least $4.0M | 102c | n/a | May 3, 2029 | Jun 30, 2023 |
| P••••••• O••• H••••• Life sciences | Sponsor not establishedpossible: I••••••• C•••••• P•••••••• L•• (a company of this name is on the sponsor's portfolio page) | 1 | at least $4.0M | 101c | n/a | Nov 16, 2028 | Dec 31, 2023 |
| I•••••••• F•••• S•• r•• Healthcare services | Sponsor not establishedpossible: S•••• C•••••• M••••••••• L•• (a company of this name is on the sponsor's portfolio page) | 2 | at least $3.9M | 101c | n/a | Apr 18, 2031 | Mar 31, 2024 |
| P••••••• P••••••• Life sciences | unattributed | 3 | at least $3.8M | 100c | n/a | Feb 28, 2029 | Mar 31, 2024 |
| E••••• A••••• H•••••• I•• Life sciences | unattributed | 3 | at least $3.8M | 100c | n/a | Oct 31, 2032 | Jun 30, 2024 |
| S••••• S•••• Life sciences | unattributed | 2 | at least $3.6M | 102c | n/a | Mar 25, 2031 | Dec 31, 2024 |
| N•••••• Life sciences | unattributed | 2 | at least $3.4M | 106c | n/a | Aug 29, 2031 | Sep 30, 2024 |
| S•••••• P••••••• H•••••••• L•• Healthcare services | Sponsor not establishedpossible: P••••••••• C•••••• (a company of this name is on the sponsor's portfolio page) | 1 | at least $3.3M | 100c | n/a | Dec 19, 2030 | Mar 31, 2025 |
| Q•• A•••• 4• P•• L•• Life sciences | unattributed | 2 | at least $3.2M | 99c | n/a | Feb 5, 2032 | Mar 31, 2026 |
| S•••••••• M••••• L•• Healthcare services | unattributed | 2 | at least $3.1M | 108c | n/a | Aug 16, 2027 | Dec 31, 2022 |
| S••••••••• D••• S•••••••• Healthcare services | unattributed | 1 | at least $3.1M | 120c | n/a | Aug 16, 2027 | Sep 30, 2024 |
| C•• M••••••• I•• Healthcare services · Life sciences | unattributed | 1 | at least $3.0M | 101c | n/a | Apr 7, 2027 | Dec 31, 2022 |
| U••• F••• a•• A•••• S••••••••• Life sciences | unattributed | 1 | at least $3.0M | 99c | n/a | Sep 15, 2026 | Dec 31, 2023 |
| n•••••• Life sciences · grade B | unattributed | 1 | at least $2.6M | 32c | n/a | Dec 15, 2028 | Dec 31, 2022 |
| H••••••••• I•• Healthcare services · Life sciences | unattributed | 2 | at least $2.5M | 100c | n/a | Jun 2, 2031 | Dec 31, 2021 |
| A•••••••• E•••••• Life sciences | unattributed | 1 | at least $2.4M | 66c | n/a | Jun 13, 2029 | Dec 31, 2022 |
| F•••••••• Life sciences | unattributed | 2 | at least $2.4M | 99c | n/a | Mar 30, 2029 | Sep 30, 2022 |
| W•••••• D••••• Life sciences | Sponsor not establishedpossible: C•••• S••••• C•••••• (a company of this name is on the sponsor's portfolio page) | 3 | at least $2.2M | 99c | n/a | Jan 30, 2032 | Dec 31, 2022 |
| T••••••••• H••••••••• S••••••••• L•• Healthcare services | Sponsor not establishedpossible: S••••• P•••••••• L••• (a company of this name is on the sponsor's portfolio page) | 2 | at least $2.2M | 100c | n/a | Jul 14, 2027 | Mar 31, 2024 |
| L••••••• G••••• C••••••••• Life sciences | unattributed | 3 | at least $2.1M | 100c | n/a | Dec 8, 2030 | Sep 30, 2022 |
| W•••••• Life sciences | unattributed | 3 | at least $2.0M | 100c | n/a | Mar 10, 2028 | Dec 31, 2022 |
| S•••••• Life sciences | unattributed | 4 | at least $1.9M | 75c | n/a | Jul 18, 2031 | Dec 31, 2022 |
| U••••••• R••••••••• Life sciences | Sponsor not establishedpossible: R••••••••• C•••••• P••••••• (a company of this name is on the sponsor's portfolio page) | 1 | at least $1.9M | 94c | n/a | Nov 20, 2029 | Dec 31, 2022 |
| G••••• H••••• Life sciences | unattributed | 1 | at least $1.9M | 98c | n/a | Jul 3, 2028 | Dec 31, 2022 |
| A•• H••••• P•••••••• I•• Healthcare services | unattributed | 3 | at least $1.9M | 100c | n/a | Sep 20, 2032 | Dec 31, 2021 |
| U•••••• I••••••••• Healthcare services | unattributed | 3 | at least $1.7M | 34c | n/a | Jul 31, 2026 | Dec 31, 2024 |
| B••• C•••• Life sciences | unattributed | 1 | at least $1.7M | 100c | n/a | Jan 21, 2031 | Dec 31, 2022 |
| N•••••• Life sciences · grade B | unattributed | 1 | at least $1.6M | 100c | n/a | Dec 31, 2028 | Dec 31, 2023 |
| C••••• M•••••• Life sciences | Sponsor not establishedpossible: S••••••••• C•••••• L• (a company of this name is on the sponsor's portfolio page) | 1 | at least $1.5M | 101c | n/a | Oct 31, 2028 | Jun 30, 2023 |
The borrower, lender and sponsor names past the first 3 rows are hidden. Open a row to reveal that record with a free account (5 a month), or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source is public either way.